94 related articles for article (PubMed ID: 12643901)
1. N-Benzoyl amino acids as LFA-1/ICAM inhibitors 1: amino acid structure-activity relationship.
Burdick DJ; Paris K; Weese K; Stanley M; Beresini M; Clark K; McDowell RS; Marsters JC; Gadek TR
Bioorg Med Chem Lett; 2003 Mar; 13(6):1015-8. PubMed ID: 12643901
[TBL] [Abstract][Full Text] [Related]
2. N-Benzoyl amino acids as ICAM/LFA-1 inhibitors. Part 2: structure-activity relationship of the benzoyl moiety.
Burdick DJ; Marsters JC; Aliagas-Martin I; Stanley M; Beresini M; Clark K; McDowell RS; Gadek TR
Bioorg Med Chem Lett; 2004 May; 14(9):2055-9. PubMed ID: 15080978
[TBL] [Abstract][Full Text] [Related]
3. 1,4-Diazepane-2-ones as novel inhibitors of LFA-1.
Wattanasin S; Albert R; Ehrhardt C; Roche D; Sabio M; Hommel U; Welzenbach K; Weitz-Schmidt G
Bioorg Med Chem Lett; 2003 Feb; 13(3):499-502. PubMed ID: 12565959
[TBL] [Abstract][Full Text] [Related]
4. Structure-activity relationship of ortho- and meta-phenol based LFA-1 ICAM inhibitors.
Lin EY; Guckian KM; Silvian L; Chin D; Boriack-Sjodin PA; van Vlijmen H; Friedman JE; Scott DM
Bioorg Med Chem Lett; 2008 Oct; 18(19):5245-8. PubMed ID: 18783948
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationship (SAR) of the α-amino acid residue of potent tetrahydroisoquinoline (THIQ)-derived LFA-1/ICAM-1 antagonists.
Zhong M; Hanan EJ; Shen W; Bui M; Arkin MR; Barr KJ; Evanchik MJ; Hoch U; Hyde J; Martell JR; Oslob JD; Paulvannan K; Prabhu S; Silverman JA; Wright J; Yu CH; Zhu J; Flanagan WM
Bioorg Med Chem Lett; 2011 Jan; 21(1):307-10. PubMed ID: 21109434
[TBL] [Abstract][Full Text] [Related]
6. Discovery and SAR of diarylsulfide cyclopropylamide LFA-1/ICAM-1 interaction antagonists.
Link JT; Sorensen B; Liu G; Pei Z; Reilly EB; Leitza S; Okasinski G
Bioorg Med Chem Lett; 2001 Apr; 11(8):973-6. PubMed ID: 11327603
[TBL] [Abstract][Full Text] [Related]
7. Competition between intercellular adhesion molecule-1 and a small-molecule antagonist for a common binding site on the alphal subunit of lymphocyte function-associated antigen-1.
Keating SM; Clark KR; Stefanich LD; Arellano F; Edwards CP; Bodary SC; Spencer SA; Gadek TR; Marsters JC; Beresini MH
Protein Sci; 2006 Feb; 15(2):290-303. PubMed ID: 16384997
[TBL] [Abstract][Full Text] [Related]
8. Decreasing the expression of LFA-1 and ICAM-1 as the major mechanism for the protective effect of caffeic acid phenethyl ester on ischemia-reperfusion injury.
Namazi H
J Plast Reconstr Aesthet Surg; 2009 Apr; 62(4):550. PubMed ID: 19195957
[No Abstract] [Full Text] [Related]
9. Statin-derived 1,3-oxazinan-2-ones as submicromolar inhibitors of LFA-1/ICAM-1 interaction: stabilization of the metabolically labile vanillyl side chain.
Ullrich T; Baumann K; Welzenbach K; Schmutz S; Camenisch G; Meingassner JG; Weitz-Schmidt G
Bioorg Med Chem Lett; 2004 May; 14(10):2483-7. PubMed ID: 15109637
[TBL] [Abstract][Full Text] [Related]
10. Amino-substituted heterocycles as isosteres of trans-cinnamides: design and synthesis of heterocyclic biaryl sulfides as potent antagonists of LFA-1/ICAM-1 binding.
Wang GT; Wang S; Gentles R; Sowin T; Leitza S; Reilly EB; von Geldern TW
Bioorg Med Chem Lett; 2005 Jan; 15(1):195-201. PubMed ID: 15582439
[TBL] [Abstract][Full Text] [Related]
11. Adxanthromycins A and B, new inhibitors of ICAM-1/LFA-1 mediated cell adhesion molecule from Streptomyces sp. NA-148. I. Taxonomy, production, isolation and biological activities.
Nakano T; Koiwa T; Takahashi S; Nakagawa A
J Antibiot (Tokyo); 2000 Jan; 53(1):12-8. PubMed ID: 10724002
[TBL] [Abstract][Full Text] [Related]
12. Natural occurrence, syntheses, and applications of cyclopropyl-group-containing alpha-amino acids. 1. 1-aminocyclopropanecarboxylic acid and other 2,3-methanoamino acids.
Brackmann F; de Meijere A
Chem Rev; 2007 Nov; 107(11):4493-537. PubMed ID: 17944521
[No Abstract] [Full Text] [Related]
13. Generation of an LFA-1 antagonist by the transfer of the ICAM-1 immunoregulatory epitope to a small molecule.
Gadek TR; Burdick DJ; McDowell RS; Stanley MS; Marsters JC; Paris KJ; Oare DA; Reynolds ME; Ladner C; Zioncheck KA; Lee WP; Gribling P; Dennis MS; Skelton NJ; Tumas DB; Clark KR; Keating SM; Beresini MH; Tilley JW; Presta LG; Bodary SC
Science; 2002 Feb; 295(5557):1086-9. PubMed ID: 11834839
[TBL] [Abstract][Full Text] [Related]
14. Identification and characterization of a human monoclonal antagonistic antibody AL-57 that preferentially binds the high-affinity form of lymphocyte function-associated antigen-1.
Huang L; Shimaoka M; Rondon IJ; Roy I; Chang Q; Po M; Dransfield DT; Ladner RC; Edge AS; Salas A; Wood CR; Springer TA; Cohen EH
J Leukoc Biol; 2006 Oct; 80(4):905-14. PubMed ID: 16888085
[TBL] [Abstract][Full Text] [Related]
15. Cell-free ligand-binding assays for integrin LFA-1.
Yuki K
Methods Mol Biol; 2012; 757():73-8. PubMed ID: 21909907
[TBL] [Abstract][Full Text] [Related]
16. The second domain of intercellular adhesion molecule-1 (ICAM-1) maintains the structural integrity of the leucocyte function-associated antigen-1 (LFA-1) ligand-binding site in the first domain.
Stanley P; McDowall A; Bates PA; Brashaw J; Hogg N
Biochem J; 2000 Oct; 351(Pt 1):79-86. PubMed ID: 10998349
[TBL] [Abstract][Full Text] [Related]
17. Involvement of adhesion molecule in in vitro plaque-like formation of macrophages stimulated with Aggregatibacter actinomycetemcomitans lipopolysaccharide.
Tsutsumi T; Nakashima K; Isoda T; Yokota M; Nishihara T
J Periodontal Res; 2010 Aug; 45(4):550-6. PubMed ID: 20412415
[TBL] [Abstract][Full Text] [Related]
18. Small molecule antagonist of leukocyte function associated antigen-1 (LFA-1): structure-activity relationships leading to the identification of 6-((5S,9R)-9-(4-cyanophenyl)-3-(3,5-dichlorophenyl)-1-methyl-2,4-dioxo-1,3,7-triazaspiro[4.4]nonan-7-yl)nicotinic acid (BMS-688521).
Watterson SH; Xiao Z; Dodd DS; Tortolani DR; Vaccaro W; Potin D; Launay M; Stetsko DK; Skala S; Davis PM; Lee D; Yang X; McIntyre KW; Balimane P; Patel K; Yang Z; Marathe P; Kadiyala P; Tebben AJ; Sheriff S; Chang CY; Ziemba T; Zhang H; Chen BC; DelMonte AJ; Aranibar N; McKinnon M; Barrish JC; Suchard SJ; Murali Dhar TG
J Med Chem; 2010 May; 53(9):3814-30. PubMed ID: 20405922
[TBL] [Abstract][Full Text] [Related]
19. Discovery of tetrahydroisoquinoline (THIQ) derivatives as potent and orally bioavailable LFA-1/ICAM-1 antagonists.
Zhong M; Shen W; Barr KJ; Arbitrario JP; Arkin MR; Bui M; Chen T; Cunningham BC; Evanchik MJ; Hanan EJ; Hoch U; Huen K; Hyde J; Kumer JL; Lac T; Lawrence CE; Martell JR; Oslob JD; Paulvannan K; Prabhu S; Silverman JA; Wright J; Yu CH; Zhu J; Flanagan WM
Bioorg Med Chem Lett; 2010 Sep; 20(17):5269-73. PubMed ID: 20655213
[TBL] [Abstract][Full Text] [Related]
20. Peptides derived from ICAM-1 and LFA-1 modulate T cell adhesion and immune function in a mixed lymphocyte culture.
Tibbetts SA; Chirathaworn C; Nakashima M; Jois DS; Siahaan TJ; Chan MA; Benedict SH
Transplantation; 1999 Sep; 68(5):685-92. PubMed ID: 10507489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
